Machine learning using clinical data at baseline predicts the medium-term efficacy of ustekinumab in patients with ulcerative colitis

Abstract Predicting the therapeutic response to biologics before administration is a key clinical challenge in ulcerative colitis (UC). We previously reported a model for predicting the efficacy of vedolizumab (VDZ) for UC using a machine-learning approach. Ustekinumab (UST) is now available for tre...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Hiromu Morikubo, Ryuta Tojima, Tsubasa Maeda, Katsuyoshi Matsuoka, Minoru Matsuura, Jun Miyoshi, Satoshi Tamura, Tadakazu Hisamatsu
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Nature Portfolio 2024-02-01
Serie:	Scientific Reports
Soggetti:	Ulcerative colitis Machine learning Ustekinumab Steroid-free clinical remission Prediction model
Accesso online:	https://doi.org/10.1038/s41598-024-55126-1
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!